PATENT CLAIM ANALYSIS

Application Number: 16228284
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["544", "376000"]

Abstract:
The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.

Claim (Index 12):
A process for producing a pharmaceutical composition comprising mixing a heterocyclic compound of the formula (1) or a salt thereof according to any one of  claims 1  to  8  with a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.19444
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15697196', '12970690', '14089504', '11659005', '14928972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8369857851242964
- 35 USC 102 Novelty (BERT): 0.5706138617409245
- Combined Prediction Score: 0.8103485927859593
- Mean Citation Score: 556.557896
- Max Citation Score: 585.1553299999998
- Similarity Product: 362.9107071501504

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test